Condition: EGFR Mutant Advanced Non-small Cell Lung Cancer · Central Nervous System (CNS) Metastases · Sponsor: Alpha Biopharma (Jiangsu) Co., Ltd.
This study is a patient-centered, two-group, three-cohort, multi-center, prospective study to further evaluate the survival benefits and safety of zorifertinib as a first-line treatment in EGFRm+ advanced NSCLC patients with CNS metastases, and to compare the clinical value of zorifertinib with other epidermal growth factor receptor tyrosine kinase inhibitors (EGFR-TKIs).
This description comes directly from the study's public registry record.
John Ge M.D. · +86 (0)21-63862197 · john.ge@alphabiopharma.com.cn
Always discuss trial participation with your own doctor first.
| The First Affiliated Hospital of Anhui Medical University | Hefei, Anhui, China | Not Yet Recruiting |
| Beijing Tumor Hospital | Beijing, Beijing Municipality, China | Not Yet Recruiting |
| Capital Medical University Affiliated Beijing Chest Hospital | Beijing, Beijing Municipality, China | Recruiting |
| Chongqing University Affiliated Cancer Hospital | Chongqing, Chongqing Municipality, China | Not Yet Recruiting |
| People's Liberation Army Army Specialized Medical Center | Chongqing, Chongqing Municipality, China | Not Yet Recruiting |
| Fujian Cancer Hospital | Fuzhou, Fujian, China | Not Yet Recruiting |
| The First Affiliated Hospital of Xiamen University | Xiamen, Fujian, China | Not Yet Recruiting |
| Foshan First People's Hospital | Foshan, Guangdong, China | Recruiting |
| Heyou Hospital, Shunde District, Foshan City | Foshan, Guangdong, China | Not Yet Recruiting |
| Guangdong Provincial People's Hospital | Guangzhou, Guangdong, China | Recruiting |
| Meizhou People's Hospital | Meizhou, Guangdong, China | Recruiting |
| Affiliated Cancer Hospital of Guangxi Medical University | Nanning, Guangxi, China | Not Yet Recruiting |
+ 22 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07143045